Coinspeaker SGEN Stock Jumps 16% in Pre-Market as Merck Set to Purchase $1B Stake in Seattle GeneticsIt is a strategic partnership that will see both Merck and Seattle Genetics venture new market opportunities as the market demand for specialized and less harmful drugs sharply increases amid the crisis.SGEN Stock Jumps 16% in Pre-Market as Merck Set to Purchase $1B Stake in Seattle Genetics